Gene Query: TSEN2

Dataset Description Geneva Score
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 28.0
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 28.0
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 13.27
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 11.75
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 10.08
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 9.78
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 9.22
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 9.22
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 7.83
EWSR1 influences alternative splicing through direct and indirect mechanisms 7.28
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 6.96
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 6.96
Cajal bodies are linked to genome conformation 6.86
Cajal bodies are linked to genome conformation [RNA-Seq] 6.86
NRDE2 negatively regulates nuclear exosome functions 6.61
LNCaP treated with iBET 6.19
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 6.13
Glioblastoma stem cells infected by ZIKA virus 5.98
Control of prostate tumour growth by the long non-coding RNA GHSROS 5.42
Gene expression analysis of the impact of TDP-43 knockout in human cells. 5.4
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 5.33
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 5.27
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 5.26
RNA-seq of tumor cells following angiopellosis extravasation 5.07
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 5.02
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.93
Transcriptional profiling of LS1034 cells treated with tepoxalin 4.8
4sUDRB-seq: measuring transcription elongation and initiation genomewide 4.7
Overexpression of NFIB and YBX1 in MCF-7 cells 4.51
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 4.49
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 4.49
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 4.45
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 4.45
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 4.42
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 4.38
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 4.36
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 4.3
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 4.3
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 4.16
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 4.1
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 4.1
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 4.03
Global Mapping of Human RNA-RNA Interactions 3.98
Illumina Total RNA-seq in HeLa 3.71
MeRIP-seq for heat shock in B-cell lymphoma cells 3.65
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 3.58
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 3.54
The landscape of alternative splicing in aggressive prostate cancers 3.53
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 3.52
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.5
Gene expression in PANC1 cells treated with Rakicidin 3.49
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 3.49
Patient-derived luminal breast cancer xenografts with progestins 3.49
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.42
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 3.39
Reassessment of Exosome Composition 3.39
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.31
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 3.23
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 3.23
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 3.22
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 3.22
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 3.16
RNA-sequencing 3.16
Total RNA-seq in ALL-SIL upon JQ1 inhibition 3.12
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 3.09
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 3.08
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.07
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.07
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 3.03
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 2.96
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 2.96
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 2.95
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.92
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 2.91
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 2.91
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 2.9
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 2.88
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 2.88
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.86
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.84
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.84
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 2.84
T47D RNA-seq and ChrRNA-seq data 2.84
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.83
RNAseq Study in CC-671 Treated Cal-51 Cells 2.82
Hypoxic transcriptome of SQ20B human head and neck cancer cells 2.8
Genome-wide discovery of human splicing branchpoints 2.79
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 2.79
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 2.78
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 2.77
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 2.77
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 2.76
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 2.73
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 2.71
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 2.71
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 2.67
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 2.61
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 2.61
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 2.58
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 2.57
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 2.56
DART-seq: an antibody-free method for global m6A detection 2.55
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 2.55
Identification of transcription start sites for human A549 cell line using ReCappable-seq 2.54
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 2.48
U2AF1 mutations alter splice site recognition in hematological malignancies 2.45
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 2.43
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 2.4
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 2.37
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 2.36
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 2.33
circRNA-sequencing 2.32
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.3
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.3
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 2.28
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 2.28
ETV7 and interferon response 2.26
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 2.26
Developmental stage specific chromosome architecture in human erythroid cells 2.25
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 2.25
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 2.24
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 2.21
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 2.21
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 2.2
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 2.14
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 2.14
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 2.11
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 2.1
Modulation of nonsense-mediated decay by rapamycin 2.06
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 2.05
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 2.04
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 2.02
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 2.02
BASP1 modifies the Tamoxifen response 2.0
Effect of drugs on transcriptomic profiles 1.99
Co-regulation of splicing by Rbfox1 and hnRNP M 1.98
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 1.98
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 1.98
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 1.97
Comprehensive comparative analysis of 5’ end RNA sequencing methods 1.97
Gene expression in GBM with Cav3.2 inhibition 1.96
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 1.96
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 1.95
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 1.95
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 1.94
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.93
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 1.92
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.89
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.89
MOF acetyl transferase regulates transcription and respiration in mitochondria 1.89
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 1.87
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 1.83
Gene expression analysis of dengue-infected cells 1.82
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 1.82
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 1.82
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 1.81
An optimization system for isolating and sequencing of single human colon cancer cells 1.81
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 1.8
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 1.8
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 1.79
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 1.79
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 1.79
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 1.78
SNHG5 siRNA knock down in HCT116 cells 1.75
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 1.75
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 1.75
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 1.75
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 1.74
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.73
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 1.73
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.72
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 1.71
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.69
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.69
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 1.69
Global analysis of alternative splicing regulated by RBM10 1.68
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 1.68
3’ Uridylation Expands miRNA Target Repertoire 1.68
HNRNPL and its RNA Targets in Prostate Cancer 1.67
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 1.67
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 1.67
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 1.67
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.65
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 1.64
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 1.64
RNA-seq analyisis of PUM2 knockout cells 1.63
Generating Patterned Kidney Organoids for Studying Development and Diseases 1.63
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 1.63
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 1.62
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.61
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.61
RNA seq analysis of human Fetal and adult derived Enterospheres 1.61
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.61
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 1.6
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 1.6
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 1.6
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 1.59
RNA sequencing of human mammary epithelial cells 1.59
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 1.58
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.57
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.57
Capturing the Interactome of Newly Transcribed RNA (RICK) 1.56
Capturing the Interactome of Newly Transcribed RNA 1.56
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 1.54
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 1.53
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 1.51
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 1.51
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 1.5
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 1.5
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 1.49
PTHrP overexpression in MCF7 cells 1.48
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 1.48
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 1.47
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 1.47
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 1.47
The pause-initiation limit restricts transcription activation in human cells 1.47
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 1.46
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 1.45
Regulation of protein translation during mitosis 1.45
RNA-seq of YB5 cells treated with Proscillaridin A 1.45
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 1.44
Hijacking of stress response machinery by oncogenes in acute leukaemia 1.44
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 1.44
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 1.43
Microprocessor mediates transcription termination in long noncoding microRNA genes 1.42
Genome-wide discovery of human splicing branchpoints [RNAse] 1.42
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.41
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 1.41
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 1.4
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 1.39
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 1.39
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.39
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.39
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.36
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 1.36
MYC dependent mRNA translation shapes gene expression and cell biology 1.35
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 1.35
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.34
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 1.32
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.32
ARS2 is a general suppressor of pervasive transcription [RNAseq] 1.32
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 1.31
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 1.31
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 1.3
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.29
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 1.29
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 1.29
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 1.29
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.29
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 1.28
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 1.28
Global transcriptome analysis of WT versus HEB-/- hESCs 1.27
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 1.27
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.25
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 1.24
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 1.24
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.22
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 1.21
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.17
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 1.17
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 1.15
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 1.15
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.15
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.15
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 1.13
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.13
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.11
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.11
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.09
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.08
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.08
Targeted enhancer activation by a subunit of the integrator complex 1.08
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 1.08
Gene expression signatures of innate lymphoid cells from human blood 1.06
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 1.05
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.05
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 1.04
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.04
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 1.03
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.03
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 1.02
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.01
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.99
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.99
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.99
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.99
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.99
N6-methyladenine DNA Modification in Glioblastoma 0.99
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.98
Global gene expression profile of dasatinib-resistant RCH-ACV cells 0.98
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.98
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 0.97
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 0.97
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 0.96
RNA-Seq with and without RNase treatment in PCa cell lines 0.95
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.95
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.95
Controlling for gene expression changes in transcription factor protein networks. 0.95
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.95
Transcriptome analysis of CNS leukemia 0.95
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 0.94
A map of gene expression in neutrophil-like cell lines 0.94
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.93
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 0.92
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 0.91
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 0.9
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.9
Global transcriptome analysis of HAP1 cells 0.89
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.88
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.87
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.85
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 0.84
Intrahepatic MAIT cell gene expression revealed by RNA-seq 0.84
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 0.83
Gene expression analysis in response to hypoxic pathway inhibition 0.83
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 0.83
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 0.83
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.81
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 0.81
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.8
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.8
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.8
UV_24h_GRO-Seq 0.79
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 0.78
Polarized B -cell functions 0.77
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 0.77
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.76
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 0.75
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.74
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 0.74
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 0.73
Genome-wide analysis of the Integrator complex (HTS) 0.71
Genome-wide analysis of the Integrator complex 0.71
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.71
TT-Seq captures the human transient transcriptome 0.71
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 0.7
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.7
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.69
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.69
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.68
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.68
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.67
Recovery and analysis of nascent RNA 0.64
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 0.64
Gene expression alterations of pancreatic intraepithlial neoplasia 0.63
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.63
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.63
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 0.62
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 0.62
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.62
MRTF activates TEAD-YAP target gene expression 0.62
Transcriptome of human white and brown adipose tissue biopsies 0.62
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.61
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.61
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.61
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.61
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.59
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.59
Epigenomic conservation of transposable element silencing 0.59
Epigenomic conservation of transposable element silencing [RNA-seq] 0.59
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.59
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.58
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.58
mRNA recovered upon RNF219 IP. [RNA-IP] 0.58
Transcriptome of activated human and mouse MAIT cells 0.58
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.57
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.57
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 0.56
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.56
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.55
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.55
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.54
HEK293 Heat-shock experiment 0.54
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.54
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 0.54
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.53
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 0.52
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 0.52
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.52
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.52
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.51
Downregulation of LATS kinases alters p53 to promote cell migration 0.5
Functional significance of the HIV-1 Tat signature amino acid residues 0.49
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.49
Oncogenic roles of ARID5B in T-ALL 0.48
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.48
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.48
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.48
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 0.47
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.47
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.45
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.44
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.44
A single cell reference map for human blood and tissue T cell activation 0.44
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.44
RNA seq with AML (NB4) cells upon FTO inhibition 0.44
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.43
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.43
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.43
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.42
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 0.41
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 0.4
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 0.4
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.4
ML29755 RNA-seq data 0.4
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.39
CDK4/6 inhibitor resistance in prostate cancer 0.39
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.38
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.37
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.36
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.36
RNAseq analysis of ruxolitinib treated breast cancers 0.36
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.36
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.35
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.35
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.34
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.34
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.34
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.34
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.33
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.32
Interphase condensins regulate ligand-depedent enhancer activation 0.32
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.32
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.32
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.32
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.31
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.31
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 0.3
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.29
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.29
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.29
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.27
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.27
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.26
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.26
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 0.26
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.25
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.25
siRNA-mediated knockdown 0.24
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.24
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.24
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.24
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.23
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.23
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.22
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.22
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.22
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 0.21
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.21
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.21
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.21
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 0.21
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.2
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.2
RNAseq of T-ALL upon long non coding rna purturbation 0.2
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.2
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.2
Transcriptome-wide modulation of splicing by the exon junction complex 0.19
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.19
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.19
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.19
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.18
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 0.17
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.17
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.16
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.16
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.16
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.14
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.13
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.13
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.13
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.13
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.13
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.12
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.12
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 0.11
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.11
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.11
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.1
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.1
Gene expression changes due to PARP knockdown in human cells 0.1
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.09
Human Tfh cell RNA bulk sequencing 0.09
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.08
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.07
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.07
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.06
Identification of long noncoding RNAs in T-ALL cell lines 0.06
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.06
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.06
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.06
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.05
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.04
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.04
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.03
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.03
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.03
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation